MYC and gastric cancer: The expression of c-Myc is remarkably high in gastric cancer, and its binding to the promoter of PDK1 regulates the expression of PDK1, which inhibits PDH activity by phosphorylating PDH, thereby reducing pyruvate conversion into acetyl coenzyme A in the tricarboxylic acid (TCA) cycle.